NCT01084941

Brief Summary

The prevalence of overweight and obesity is increasing among pregnant women in the United States. More than one-third of women of reproductive age in the US are overweight or obese, and two thirds of women gain more weight in pregnancy than is recommended by the Institute of Medicine guidelines. Maternal obesity during pregnancy increases the risk of complications to both mother and child. Minority women (Blacks and Hispanics) have higher rates of overweight and obesity when they become pregnant, experience higher rates of excessive weight gain during pregnancy, and experience higher rates of maternal and neonatal complications after adjusting for sociodemographic characteristics and comorbidities than Caucasian women. Epidemiologic studies indicate that lifestyle modification programs based on diet and exercise are promising approaches in controlling weight gain as well as in preventing type 2 diabetes in populations at risk. We hypothesize that overweight/obese minority women (Blacks and Hispanics) assigned to a culturally-grounded lifestyle intervention program based on diet and moderate exercise will result in higher compliance with Institute of Medicine guidelines for weight gain than women receiving standard care. Such lifestyle modifications should reduce risk of maternal and neonatal complications. We propose 1) to determine whether a lifestyle intervention program, based on diet and moderate physical activity implemented shortly after first recognition of pregnancy, will result in higher compliance with Institute of Medicine guidelines for weight gain compared to women receiving standard care; 2) to determine the occurrence of carbohydrate intolerance and GDM at 24-28 weeks gestation (after the first 10-12 weeks of intervention) and at 6 weeks postpartum between women in the lifestyle intervention group and women receiving standard care; and 3) to explore the impact of the lifestyle intervention on the development of maternal and fetal complications during pregnancy. By limiting excessive weight gain, the lifestyle intervention program may prevent the burden of obesity-related complications during pregnancy and reduce risk of subsequently developing overt diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for phase_4 pregnancy

Timeline
Completed

Started Apr 2010

Typical duration for phase_4 pregnancy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 9, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 11, 2010

Completed
21 days until next milestone

Study Start

First participant enrolled

April 1, 2010

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

November 21, 2013

Status Verified

July 1, 2013

Enrollment Period

2.7 years

First QC Date

March 9, 2010

Last Update Submit

November 20, 2013

Conditions

Keywords

pregnancyweight gainobesitypregnancy and weight gain

Outcome Measures

Primary Outcomes (1)

  • The primary outcome is whether a woman's weight gain follows the Institute of Medicine's recommendations for pregnancy weight gain.

    36 weeks

Secondary Outcomes (2)

  • To compare the occurrence of carbohydrate intolerance and GDM at 24-28 weeks gestation and after delivery between women in the lifestyle intervention group and women receiving standard care.

    36 weeks

  • To explore the impact of the lifestyle intervention in preventing maternal and fetal complications between women in the lifestyle intervention group and women receiving standard care.

    36 weeks

Study Arms (2)

Lifestyle intervention

EXPERIMENTAL

Women on the intervention group will participate in a lifestyle program based on diet and moderate physical activity implemented shortly after first recognition of pregnancy. These women will attend monthly nutrition and physical activity educational sessions, and receive booster every 2 weeks.

Behavioral: Lifestyle Intervention group

Standard of care group

ACTIVE COMPARATOR

Patients randomized to the standard of care group will receive counseling routinely provided to all prenatal care women as recommended by the Institute of Medicine for appropriate nutrition and weight gain and ACOG guidelines for appropriate physical activity during pregnancy.

Behavioral: Standard of Care

Interventions

Women on the intervention group will participate in a lifestyle program based on diet and moderate physical activity implemented shortly after first recognition of pregnancy. These women will attend monthly nutrition and physical activity educational sessions, and receive booster every 2 weeks.

Lifestyle intervention

Patients randomized to the standard of care group will receive counseling routinely provided to all prenatal care women as recommended by the Institute of Medicine for appropriate nutrition and weight gain and ACOG guidelines for appropriate physical activity during pregnancy.

Standard of care group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Blacks and Hispanic
  • women between 18-45 years of age;
  • \) overweight and obese (BMI \> 25 kg/m2),
  • \) have a sedentary lifestyle (\<30 minutes/day of moderate physical activity), and
  • \) prenatal care established at less than 20 weeks of gestation,
  • \) with a singleton pregnancy.

You may not qualify if:

  • Women with 1) age \< 18 or \> 45 years,
  • \) \> 20 weeks gestation,
  • \) history of diagnosis of type 2 diabetes, hypertension, cardiovascular disease, chronic renal disease, and active liver disease (AST \> 3 ULN),
  • \) anemia (hemoglobin \< 10 g, hematocrit \< 32%);
  • \) current medications which adversely influence glucose tolerance (corticosteroids),
  • \) multiple pregnancy,
  • \) women not planning to continue pregnancy to term, 7) contraindications to participate in regular physical activity,
  • \) patients with mental conditions rendering them unable to understand the nature, scope, and possible consequences of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Grady Memorial Hospital

Atlanta, Georgia, 30303, United States

Location

MeSH Terms

Conditions

Weight GainObesityGestational Weight Gain

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Body Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsOverweightOvernutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Guillermo Umpierrez, MD

    Emory University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

March 9, 2010

First Posted

March 11, 2010

Study Start

April 1, 2010

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

November 21, 2013

Record last verified: 2013-07

Locations